Posts by Katelyn Wiard

FDA Approval of Epidiolex: No Legal Impact on Hemp-Derived CBD

Yesterday, as long anticipated, the Food and Drug Administration (FDA) approved GW Pharmaceutical’s Epidiolex, a cannabidiol (CBD) oral solution for the treatment of seizures associated with two forms of epilepsy.  Please see the FDA’s press release here, and this statement from the FDA’s Commissioner. The US Hemp Roundtable has reviewed the release with its FDA…

Read More

URGENT – Your Immediate Action is Needed to Save Hemp Legalization

  Late this afternoon, U.S. Sen. Chuck Grassley (R-IA) filed an amendment to the 2018 Farm Bill which would devastate the industry’s efforts to promote full legalization of hemp and hemp products. Specifically, Grassley’s amendment (here) would explicitly exclude “cannabinoids,” “extracts” and “derivatives” from the definition of hemp. This could mean that popular products such as…

Read More